Innate immunity in disease

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 5, 2014, Pages 749-755

  Elliott, David E ^a   Siddique, Sana S ^b   Weinstock, Joel V ^b  

^a UNIVERSITY OF IOWA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Colitis; Gastroenterology; Innate Immunity; Mucosa

Indexed keywords

PATTERN RECOGNITION RECEPTOR; CYTOKINE;

ADAPTIVE IMMUNITY; ARTICLE; BIOME; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTESTINE FUNCTION; NONHUMAN; GASTROINTESTINAL DISEASE; IMMUNOLOGY; LEUKOCYTE; METABOLISM; PATHOLOGY;

CYTOKINES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; RECEPTORS, PATTERN RECOGNITION;

EID: 84898688659     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.03.007     Document Type: Article

References (59)

1. Fritz J.H., Le Bourhis L., Magalhaes J.G., et al. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol 2008, 29:41-49.
2. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
3. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. JLeukoc Biol 2007, 81:1-5.
4. Cader M.Z., Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013, 62:1653-1664.
5. Zigmond E., Jung S. Intestinal macrophages: well educated exceptions from the rule. Trends Immunol 2013, 34:162-168.
6. Mosser D.M. The many faces of macrophage activation. JLeukoc Biol 2003, 73:209-212.
7. Dzopalic T., Rajkovic I., Dragicevic A., et al. The response of human dendritic cells to co-ligation of pattern-recognition receptors. Immunol Res 2012, 52:20-33.
8. Farache J., Zigmond E., Shakhar G., et al. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol 2013, 91:232-239.
9. Hwang Y.Y., McKenzie A.N. Innate lymphoid cells in immunity and disease. Adv Exp Med Biol 2013, 785:9-26.
10. Eberl G., Marmon S., Sunshine M.J., et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004, 5:64-73.
11. Neill D.R., Wong S.H., Bellosi A., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
12. Mjosberg J.M., Trifari S., Crellin N.K., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
13. Geremia A., Arancibia-Carcamo C.V., Fleming M.P., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. JExp Med 2011, 208:1127-1133.
14. Brown A.C., Dobbie I.M., Alakoskela J.M., et al. Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins. Blood 2012, 120:3729-3740.
15. Sandig H., Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front Immunol 2012, 3:185.
16. St John A.L., Abraham S.N. Innate immunity and its regulation by mast cells. JImmunol 2013, 190:4458-4463.
17. Bischoff S.C., Lorentz A., Schwengberg S., et al. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999, 44:643-652.
18. Iikura M., Suto H., Kajiwara N., et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007, 87:971-978.
19. Jaillon S., Galdiero M.R., Del Prete D., et al. Neutrophils in innate and adaptive immunity. Semin Immunopathol 2013, 35:377-394.
20. Thomas C.J., Schroder K. Pattern recognition receptor function in neutrophils. Trends Immunol 2013, 34:317-328.
21. Goldmann O., Medina E. The expanding world of extracellular traps: not only neutrophils but much more. Front Immunol 2012, 3:420.
22. Radic M., Marion T.N. Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol 2013, 35:465-480.
23. Pelletier M., Maggi L., Micheletti A., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
24. Puga I., Cols M., Barra C.M., et al. Bcell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012, 13:170-180.
25. Jaeger B.N., Donadieu J., Cognet C., et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. JExp Med 2012, 209:565-580.
26. Szabady R.L., McCormick B.A. Control of neutrophil inflammation at mucosal surfaces by secreted epithelial products. Front Immunol 2013, 4:220.
27. Mrsny R.J., Gewirtz A.T., Siccardi D., et al. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc Natl Acad Sci U S A 2004, 101:7421-7426.
28. Melo R.C., Liu L., Xenakis J.J., et al. Eosinophil-derived cytokines in health and disease: unraveling novel mechanisms of selective secretion. Allergy 2013, 68:274-284.
29. Rosenberg H.F., Dyer K.D., Foster P.S. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013, 13:9-22.
30. Hogan S.P., Waddell A., Fulkerson P.C. Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol 2013, 29:7-14.
31. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 2011, 242:161-177.
32. Shamri R., Xenakis J.J., Spencer L.A. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011, 343:57-83.
33. Yousefi S., Simon D., Simon H.U. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol 2012, 24:736-739.
34. Reynolds J.M., Martinez G.J., Nallaparaju K.C., et al. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. JImmunol 2012, 189:4226-4230.
35. Ramirez-Carrozzi V., Sambandam A., Luis E., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 2011, 12:1159-1166.
36. Frantz A.L., Rogier E.W., Weber C.R., et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol 2012, 5:501-512.
37. Gong J., Xu J., Zhu W., et al. Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin Immunol 2010, 136:245-256.
38. Johansson M.E., Larsson J.M., Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4659-4665.
39. Vaishnava S., Yamamoto M., Severson K.M., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
40. Clevers H.C., Bevins C.L. Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol 2013, 75:289-311.
41. Schnupf P., Gaboriau-Routhiau V., Cerf-Bensussan N. Host interactions with Segmented Filamentous Bacteria: an unusual trade-off that drives the post-natal maturation of the gut immune system. Semin Immunol 2013, 25:342-351.
42. Silva P.A., Borba V.H., Dutra J.M., et al. Anew ascarid species in cynodont coprolite dated of 240 million years. An Acad Bras Cienc 2014 Jan 29, Epub ahead of print.
43. Fumagalli M., Pozzoli U., Cagliani R., et al. The landscape of human genes involved in the immune response to parasitic worms. BMC Evol Biol 2010, 10:264.
44. Elliott D.E., Weinstock J.V. Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci 2012, 1247:83-96.
45. Netea M.G., van de Veerdonk F.L., van der Meer J.W. Primary immunodeficiencies of pattern recognition receptors. JIntern Med 2012, 272:517-527.
46. Fukata M., Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013, 6:451-463.
47. Hiemstra I.H., Bouma G., Geerts D., et al. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses. Mol Immunol 2012, 52:264-272.
48. Abonia J.P., Blanchard C., Butz B.B., et al. Involvement of mast cells in eosinophilic esophagitis. JAllergy Clin Immunol 2010, 126:140-149.
49. Aceves S.S., Chen D., Newbury R.O., et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. JAllergy Clin Immunol 2010, 126:1198-1204.
50. Wehkamp J., Salzman N.H., Porter E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 2005, 102:18129-18134.
51. Salzman N.H., Hung K., Haribhai D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010, 11:76-83.
52. Hiby S.E., Walker J.J., O'Shaughnessy K.M., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. JExp Med 2004, 200:957-965.
53. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305:872-874.
54. Vivian J.P., Duncan R.C., Berry R., et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011, 479:401-405.
55. Gleich G.J., Klion A.D., Lee J.J., et al. The consequences of not having eosinophils. Allergy 2013, 68:829-835.
56. Seidel U.J., Schlegel P., Lang P. Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies. Front Immunol 2013, 4:76.
57. Abraham B.P., Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am 2012, 41:483-495.
58. Hueber W., Sands B.E., Lewitzky S., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012, 61:1693-1700.
59. Iwasa T., Nakamura K., Ogino H., et al. Multiple ulcers in the small and large intestines occurred during tocilizumab therapy for rheumatoid arthritis. Endoscopy 2011, 43:70-72.